Bolivia. Trip notes: FX shortage reaches alarming levels

  • FX market conditions have materially worsened, with increased restrictions and widening parallel rate gap

  • No corrections expected in the short term and little hope of policy reversal after the 2025 elections

  • We uphold our neutral positioning on bonds, as supportive technical factors mitigate weak macro fundamentals
This is a premium report that requires access to BancTrust & Co.


Sub-Saharan Africa


BancTrust & Co. is a boutique investment banking group highly specialised in Emerging Markets Debt with a primary focus on high beta credit markets in Latin America and Central & Eastern Europe, the Middle East & Africa.


Treasury products and services
BancTrust & Co. provide financial products and services to corporations, financial institutions and government entities in emerging and frontier markets. Our Global Markets team focuses on high beta credit markets in Latin America, the Caribbean, and CEEMEA. Meanwhile, our Capital Markets team offers custom financing solutions for EM-based entities.
Reports and events
BancTrust & Co. shares its views on frontier and emerging markets within Latin America, the Caribbean, Sub-Saharan Africa and Emerging Europe by regularly publishing research reports on sovereign and corporate fixed income, credit strategy, as well as economic, quantitative and political analysis. The firm actively sponsors and participates in various EM-dedicated conferences and industry events in partnership with the City of London, EMTA, Canning House and/or other trade associations and NGOs.


This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not constitute investment recommendation, and nor is it investment, legal or tax advice or an offer or solicitation to purchase or sell any financial instrument.

This publication is not intended for distribution to, or use by, any person or entity in any jurisdiction in any country where such distribution or use would be contrary to law or regulation, or which would subject Tellimer to any registration requirement within such jurisdiction or country.

This research is produced by a third party. The Tellimer team has had no editorial input into the content of the note.